Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Number of holders
-
18
-
Total 13F principal, excl. options
-
49,835,500
-
Principal change
-
+341,000
-
Total reported value, excl. options
-
$49,938,000
-
Value change
-
+$366,667
-
Number of buys
-
2
-
Number of sells
-
-11
-
Price
-
$1.00
Significant Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q3 2021
22 filings reported holding 464337AJ3 - ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q3 2021.
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 has 18 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $49,835,500 of principal
.
Largest 10 bondholders include OAKTREE CAPITAL MANAGEMENT LP ($18,208,000 of principal), BNP Paribas Asset Management Holding S.A. ($7,000,000 of principal), Polygon Management Ltd. ($6,725,000 of principal), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ($5,950,000 of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($5,157,000 of principal), Russell Investments Group, Ltd. ($3,923,000 of principal), PALISADE CAPITAL MANAGEMENT LLC/NJ ($2,126,000 of principal), MORGAN STANLEY ($364,000 of principal), Castle Creek Arbitrage, LLC ($150,000 of principal), and WELLS FARGO & COMPANY/MN ($103,500 of principal).
This table shows the top 18 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.